Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of
nitazoxanide-peginterferon alfa-2b combination therapy compared to peginterferon monotherapy
in patients that are treatment naive or pre-treated for 24 weeks with nitazoxanide
monotherapy in the treatment of chronic hepatitis C.